View Post

Immunotherapy Expands Treatment Options for Metastatic Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Danielle Ternyila From: targetedonc.com Several recent updates from clinical trials are transforming the treatment landscape for urothelial carcinoma across a variety of subtypes. The use of immunotherapy, in particular, provides patients who progress after standard platinum-based chemotherapy with new hope and a plethora of options. In the metastatic setting, there have been 5 immune checkpoint inhibitors approved by the …

View Post

Targeting Innovation in Small Cell Lung Cancer

In Clinical Trials by Barbara Jacoby

By: Heather Stringer From: curetoday.com After consulting multiple doctors about her ongoing cough and congestion, LeeAnn Devore asked one of her physicians if she might have lung cancer. “He said the symptoms weren’t right,” says Devore, 66, of Magnolia, Texas. Three X-rays in five months confirmed that she had pneumonia in her right lung, yet she wasn’t responding to traditional …

View Post

FREE Immunotherapy Patient Summit – Houston, Sat, December 8, 2018

In Clinical Trials by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, December 8, 2018 – 10:00 AM – 3:30 PM PDT Hosted at MD Anderson Cancer Center Dan L. Duncan Cancer Prevention Building, (CPB) – 8th Floor Conference Center 1155 Pressler Street Houston, TX 77030 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

FREE Immunotherapy Patient Summit – Houston, Sat, December 8, 2018

In In The News by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, December 8, 2018 – 10:00 AM – 3:30 PM PDT Hosted at MD Anderson Cancer Center Dan L. Duncan Cancer Prevention Building, (CPB) – 8th Floor Conference Center 1155 Pressler Street Houston, TX 77030 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

9 things to know about CAR T-cell therapy

In Clinical Trials by Barbara Jacoby

By: Cynthia DeMarco From: mdanderson.org CAR T-cell therapy is a new type of cancer treatment offered at MD Anderson through clinical trials and FDA-approved standard of care cell therapy products. But what exactly is CAR T-cell therapy? And who should consider it? We spoke with Sattva Neelapu, M.D., to learn more. Here’s what he had to say. Let’s start with the …

View Post

Give way to the immune system: immunotherapy prior to surgery instead of after

In In The News by Barbara Jacoby

Source: Netherlands Cancer Institute Physicians can possibly use immunotherapy in cancer patients more effectively. More and more voices are in favor of giving this new treatment before the surgeon removes a tumor instead of afterwards. This could have huge benefits, like a better immune response against the tumor. On 22 October,  researcher Christian Blank and his colleagues at the Netherlands …

View Post

FREE Immunotherapy Patient Summit – San Diego, Sat, October 27, 2018

In In The News by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, October 27, 2018 – 10:00 AM – 3:30 PM PDT Hosted at UC San Diego School of Medicine T. Denny Sanford Medical Education and Telemedicine Center 9500 Gilman Drive La Jolla, CA 92092 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

Gamma Knife™, Immunotherapy Combo Shows Promise in Managing Certain Brain Tumors

In In The News by Barbara Jacoby

With metastatic melanoma cases on the rise, doctors continue to search for effective treatment solutions for controlling brain tumors. Industry-leading San Diego Gamma Knife Center® says therapies combining stereotactic radiosurgery and certain immunotherapies could be the key the medical community has been searching for. Over the past 10 years, diagnoses of new cases of melanoma, the most dangerous form of skin cancer, have …

View Post

This Woman’s Terminal Breast Cancer Disappeared After Immunotherapy. Here’s Why That’s Such a Big Deal

In In The News by Barbara Jacoby

By: AMANDA MACMILLAN From: health.com When Judy Perkins enrolled in an experimental trial, she only had months to live. Two years later, she’s cancer-free. Metastatic breast cancer, a term for advanced breast cancer that’s spread to other parts of the body, is a devastating diagnosis: Its average life expectancy is just three years, and its five-year survival rate is just 22%. …

View Post

Could baking soda improve cancer treatment?

In In The News by Barbara Jacoby

By: Tim Newman From: medicalnewstoday.com Consuming baking soda may help immunotherapy drugs to fight difficult-to-treat tumors. This cheap and simple intervention may eventually improve current cancer treatmentsi Within tumors, large portions are deprived of oxygen. Scientists know that these hypoxic regions tend to be the most resistant to treatment. If a cell is unable to access adequate oxygen, it slows …